SCHEMBL26033264

SCHEMBL26033264

CC(=O)N1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(-c4ccccn4)c3)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 6/20 0.54
LCK P06239 5/20 0.54
KIT P10721 4/20 0.53
MAPK14 Q16539 3/20 0.53
EGFR P00533 2/20 0.53
KDR P35968 2/20 0.53
ERBB4 Q15303 1/20 0.53
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
RAB9A P51151 1/20 0.52
ABL1 P00519 5/20 0.52
ABL2 P42684 2/20 0.52
BTK Q06187 1/20 0.49
LMNA P02545 2/20 0.48
BCR P11274 2/20 0.48
PLK4 O00444 1/20 0.48
DDX3X O00571 1/20 0.48
GAK O14976 1/20 0.48
SLC22A2 O15244 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016677 0.91 LMNA (0.50) EGFRKDM4EALDH1A1MAPTRAB9A
SCHEMBL12214664 0.90 ALDH1A1 (0.49) CSF1RLCKKITEGFRKDM4E
SCHEMBL1017567 0.81 BTK (0.58) CSF1RLCKKITMAPK14EGFR
SCHEMBL2619308 0.81 BTK (0.57) CSF1RLCKKITMAPK14EGFR
SCHEMBL1016804 0.79 CYP3A4 (0.55) RAB9AALBCYP3A4ABCG2
SCHEMBL26033258 0.79 CSF1R (0.54) CSF1RLCKKITMAPK14EGFR
SCHEMBL12974826 0.79 IKBKE (0.47) CSF1RLCKKITMAPK14EGFR
SCHEMBL26033294 0.79 ABL1 (0.53) MAPK14RAB9AABL1
SCHEMBL26033252 0.79 HDAC1 (0.53) MAPK14KDRRAB9AABL1RAF1
SCHEMBL12727164 0.79 RAB9A (0.53) KDM4EALDH1A1MAPTRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO CSF1R 256/4885LCK 1002/4885KIT 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.